{"id":"https://openalex.org/W2977520331","doi":"https://doi.org/10.14309/00000434-201610001-00740","title":"Inflammatory Cytokines in Patients with Inflammatory Bowel Diseases That Don\u02bct Respond to Optimal Anti-Tumor Necrosis Factor Therapy","display_name":"Inflammatory Cytokines in Patients with Inflammatory Bowel Diseases That Don\u02bct Respond to Optimal Anti-Tumor Necrosis Factor Therapy","publication_year":2016,"publication_date":"2016-10-01","ids":{"openalex":"https://openalex.org/W2977520331","doi":"https://doi.org/10.14309/00000434-201610001-00740","mag":"2977520331"},"language":"en","primary_location":{"id":"doi:10.14309/00000434-201610001-00740","doi":"https://doi.org/10.14309/00000434-201610001-00740","is_oa":false,"landing_page_url":"https://doi.org/10.14309/00000434-201610001-00740","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034738993","display_name":"Andres J. Yarur","orcid":"https://orcid.org/0000-0003-2293-5555","observed_orcids":["https://orcid.org/0000-0003-2293-5555"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andres Yarur","raw_affiliation_strings":["Medical College of Wisconsin, Milwaukee, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical College of Wisconsin, Milwaukee, WI","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009375239","display_name":"Anjali Jain","orcid":"https://orcid.org/0000-0001-5658-367X","observed_orcids":["https://orcid.org/0000-0001-5658-367X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anjali Jain","raw_affiliation_strings":["Prometheus Laboratories, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratories, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019378404","display_name":"Maria A. Quintero","orcid":"https://orcid.org/0000-0003-2249-6564","observed_orcids":["https://orcid.org/0000-0003-2249-6564"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Alejandra Quintero","raw_affiliation_strings":["University of Miami, Pembroke Pines, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami, Pembroke Pines, FL","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012357829","display_name":"Maria Teresa Abreu","orcid":"https://orcid.org/0000-0002-7294-0574","observed_orcids":["https://orcid.org/0000-0002-7294-0574"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria T. Abreu","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL","institution_ids":["https://openalex.org/I145608581"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24996519,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"111","issue":null,"first_page":"S332","last_page":"S333"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.8550000190734863},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":1.0},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9229999780654907},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/endoscopic-inflammation","display_name":"endoscopic inflammation","score":0.8389999866485596},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.9129999876022339},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.7900000214576721},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7149999737739563},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.9610000252723694},{"id":"https://openalex.org/keywords/vcam-1","display_name":"VCAM-1","score":0.8569999933242798},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.6650000214576721},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7170000076293945},{"id":"https://openalex.org/keywords/treatment-resistance-prediction","display_name":"treatment resistance prediction","score":0.3709999918937683},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9510555267333984},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7799807786941528},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.6830617785453796},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.650162935256958},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6295915842056274},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.6187934875488281},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5875879526138306},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.5608683824539185},{"id":"https://openalex.org/C2778435480","wikidata":"https://www.wikidata.org/wiki/Q840387","display_name":"Colonoscopy","level":4,"score":0.46422192454338074},{"id":"https://openalex.org/C2781195455","wikidata":"https://www.wikidata.org/wiki/Q422766","display_name":"C-reactive protein","level":3,"score":0.4624192416667938},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4181508421897888},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3901442885398865},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2768303155899048},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.18251758813858032},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15741011500358582}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/00000434-201610001-00740","doi":"https://doi.org/10.14309/00000434-201610001-00740","is_oa":false,"landing_page_url":"https://doi.org/10.14309/00000434-201610001-00740","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8500000238418579}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2793599703","https://openalex.org/W2793904479","https://openalex.org/W3147439200","https://openalex.org/W2904003034","https://openalex.org/W2315668427","https://openalex.org/W1968760412","https://openalex.org/W3015918280","https://openalex.org/W4405985759","https://openalex.org/W4252579601","https://openalex.org/W2025386944"],"abstract_inverted_index":{"Introduction:":[0],"Anti-tumor":[1],"necrosis":[2],"factor":[3],"\u03b1":[4],"(ATNF)":[5],"agents":[6],"have":[7,51],"been":[8],"found":[9],"to":[10,267,309],"be":[11,317],"efficacious":[12],"in":[13,18,220,242,256,284,301,333,340,350],"the":[14,89,92,156,164,302,347],"treatment":[15],"of":[16,30,45,53,91,98,158,166,211,245,277,306,357],"remission":[17],"Crohn's":[19],"disease":[20],"(CD)":[21],"and":[22,75,94,102,113,118,136,191,213,232,263,329],"ulcerative":[23],"colitis":[24],"(UC).":[25],"Unfortunately,":[26],"a":[27,60,235],"significant":[28],"amount":[29],"patients":[31,41,66,173,197,246,261,307,334,352],"present":[32],"with":[33,42,67,76,174,204,240,247,262,281,313,335],"primary":[34,153],"or":[35,69,73,304],"secondary":[36],"non-response.":[37],"We":[38],"hypothesized":[39],"that":[40,64,296,327],"therapeutic":[43],"levels":[44,79,210,258,312],"anti-TNF":[46,336],"but":[47,215],"ongoing":[48],"endoscopic":[49,160,201,282],"inflammation":[50,161,206,241,283],"elevations":[52],"alternative":[54,298],"inflammatory":[55,279,299,321],"pathways.":[56],"Methods:":[57],"This":[58],"is":[59],"prospective":[61],"cross-sectional":[62],"study":[63],"included":[65,95],"CD":[68],"UC":[70],"receiving":[71,227],"infliximab":[72],"adalimumab":[74],"optimal":[77,175],"drug":[78],"(\u22658":[80],"mg/mL)":[81],"undergoing":[82],"colonoscopy.":[83],"Predictive":[84],"variables":[85],"were":[86,120,139,178,189,323,331],"recorded":[87],"at":[88,167],"time":[90],"procedure":[93],"demographics,":[96],"phenotype":[97],"disease,":[99],"current/previous":[100],"medications":[101],"laboratory":[103],"results":[104,294],"(C-reactive":[105],"protein,":[106],"hemoglobin,":[107],"albumin,":[108],"white":[109],"blood":[110],"cell":[111,128],"count":[112],"infliximab/adalimumab":[114],"levels).":[115],"Multiple":[116],"cytokines":[117,280,322],"biomarkers":[119,222],"measured":[121,140],"including":[122],"intercellular":[123],"adhesion":[124,129],"molecule-1":[125,130],"(ICAM-1),":[126],"vascular":[127],"(VCAM-1),":[131],"interleukins":[132],"(IL)":[133],"8,":[134],"1\u03b2":[135],"6.":[137],"Cytokines":[138],"using":[141,142],"ELISA":[143],"(multiplex":[144],"kit":[145],"from":[146],"Meso":[147],"Scale":[148],"Discovery":[149],"[Maryland,":[150],"USA]).":[151],"The":[152,180],"outcome":[154],"was":[155,183,217,253],"presence":[157,165],"active":[159,200,205,314],"defined":[162],"as":[163],"least":[168],"one":[169],"ulceration.":[170],"Results:":[171],"51":[172],"medical":[176],"therapy":[177],"included.":[179],"mean":[181],"age":[182],"39":[184],"(SD:":[185],"15),":[186],"27":[187],"(53%)":[188],"men":[190],"4":[192],"(7.8%)":[193],"had":[194,199,207,234],"UC.":[195],"24":[196],"(47%)":[198],"disease.":[202],"Patients":[203],"significantly":[208],"higher":[209],"ICAM-1":[212],"IL-1b":[214,233,330],"there":[216],"no":[218,254],"difference":[219,255],"other":[221],"(Table":[223,250],"1).":[224],"When":[225],"calculating":[226],"operating":[228],"characteristic":[229],"curves,":[230],"ICAM":[231],"good":[236],"correlation":[237],"(ROC":[238],"\u22650.8)":[239],"this":[243],"cohort":[244],"\u201cATNF":[248],"resistance\u201d":[249],"2).":[251],"There":[252],"cytokine":[257,348],"between":[259],"those":[260],"without":[264],"previous":[265],"exposure":[266],"another":[268],"ATNF":[269],"agent":[270],"(p>0.05":[271],"for":[272],"all).Table":[273],"1Table":[274],"2:":[275],"Association":[276],"multiple":[278],"Anti-TNF":[285],"resistance":[286,337],"patientsConclusion:":[287],"While":[288],"larger":[289],"studies":[290],"are":[291],"warranted,":[292],"our":[293],"suggest":[295],"examining":[297],"pathways":[300,343],"tissues":[303],"serum":[305],"refractory":[308],"anti-TNFs":[310],"(therapeutic":[311],"inflammation)":[315],"may":[316,338,353],"helpful.":[318],"Not":[319],"all":[320],"elevated.":[324],"Our":[325],"finding":[326],"ICAM1":[328],"elevated":[332],"result":[339],"targeting":[341],"these":[342,351],"therapeutically.":[344],"Thus,":[345],"measuring":[346],"profile":[349],"guide":[354],"rational":[355],"selection":[356],"second":[358],"line":[359],"agents.Figure":[360],"1":[361]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2019-10-10T00:00:00"}